Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Chemistree Technology Inc. (C:CHM)

Business Focus: Pharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for CHM within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jan 10, 2020 08:00 ET
Chemistree to Unveil VR Tour of Sugarleaf Facility at Lift - Vancouver
VANCOUVER, Jan. 10, 2020 /CNW/ - Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), announces that in conjunction with the January 10 and 11, 2020, Lift & Co Cannabis Expo in Vancouver Canada, Chemistree will unveil for our shareholders and potential new investors - a bold and exciting new virtual reality tour of our state-of-the-art Washington facility, to illustrate first hand what we do, and how we do it.
Read full article
Oct 07, 2019 18:45 ET
Chemistree Cancels PCCBD Investment
VANCOUVER, Oct. 7, 2019 /CNW/ - Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), announces that the proposed investment into The Physician's Choice CBD ("PCCBD") of Phoenix, Arizona, as previously announced in April 2019, has been terminated.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
-0.82
--
--
Price to Sales - TTM
11.58
4.09
8.90
Price to Book - most recent quarter
1.31
2.06
2.31
Price to Cash Flow per share - TTM
--
8.19
9.87
Price to Free Cash Flow per share - TTM
--
14.00
17.21
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Dec 31, 201932,5500
Nov 15, 20195,0000
Oct 15, 2019370-23,465
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Chemistree Technology Inc. is a Canada-based investment company that focuses on investing in the United States cannabis sector. The Company provides solutions for the regulated cannabis industry. The Company owns assets in Washington State used to operate the Sugarleaf brand, cannabis cultivation lands in California, interest in Humboldt County and California cannabis processing company. The Company holds interest in Pasha Brands. The Company's subsidiaries include Chemistree Washington Ltd., CHM Desert LLC and American CHM Investments Inc.

See business summary

Twitter

Search (past week) for $CHM.CA

  • No tweets found